# Quebec SEAO #VB-AAI-20261110

MRI contrast-agent injector for Santé Québec Laurentides

**Posted:** November 10, 2026
**Respond By:** November 18, 2026
**Identifier:** VB-AAI-20261110
**NAICS:** 334510, 423490

Santé Québec Laurentides is seeking suppliers for an MRI contrast-agent injector that meets clinical, safety, and language requirements.
- **Buyer:** Santé Québec Laurentides, within Santé Québec; responses are directed to CISSS des Laurentides.
- **OEMs and vendors:** No manufacturer, OEM, or supplier is named in the opportunity.
- **Requested product:** One type of MRI contrast-agent injector; quantity, model, and part number are not specified.
- **Key requirements:** Programmable, constant-rate injection of contrast agent and saline; adjustable volume, rate, and maximum pressure; contrast-agent temperature maintenance; and features to reduce supply costs and agent use.
- **Safety and operation:** Air-bubble and extravasation detection; safe MRI operation using non-ferromagnetic materials; self-diagnostics with displayed fault reports; French-language controls, screen, and software.
- **Installation and controls:** Suppliers must describe ceiling-suspended, mobile-stand, and examination-table mounting options and installation requirements. An independent control unit for the control room is also required.
- **Supplier information requested:** Product documentation, compatible-supply information, timelines for any pending Health Canada approvals, and Quebec reference sites.
- **Timing and value:** No period of performance, delivery schedule, or estimated contract value is provided.

### Description

Santé Québec Laurentides is seeking expressions of interest from suppliers able to provide a contrast-agent injector for magnetic resonance imaging (MRI). The device must support programmable, constant-rate injection of contrast agent and saline, temperature maintenance, supply-use reduction features, advanced safety features, and safe use in an MRI environment. Suppliers must provide written confirmation of supply capability, a completed questionnaire, product documentation, compatible-supplies information, any pending Health Canada approval timelines, and Quebec reference sites. Responses are due by email to CISSS des Laurentides by November 18, 2026, at 12:00 p.m. Quebec Legal Time.

[View original listing](https://seao.gouv.qc.ca/avis-resultat-recherche/consulter?ItemId=e0cf6f94-82f8-45f2-af70-661988c07bb5)